의료용 페이스 실드 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 용도별, 실드 소재별, 최종 용도별, 지역별 및 부문별 전망(2026-2033년)

Medical Face Shield Market Summary

The global medical face shield market size was valued at USD 255.9 million in 2025 and is projected to grow from USD 268.5 million in 2026 to USD 389.3 million by 2033, at a CAGR of 5.5% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 34.5% in 2025. The medical face shield market is shaped by healthcare worker safety requirements, infection-control practices, and the need for protection against respiratory droplets, blood splashes, and other potentially infectious materials during clinical procedures.

Demand for face shields is supported in emergency care, surgery, dentistry, laboratory work, and other environments involving close patient contact or splash hazards. Product development is focused on improving optical clarity, lightweight construction, anti-fog performance, comfort, adjustability, and compatibility with masks, respirators, eyewear, and other personal protective equipment.

Stronger infection prevention and control practices are supporting the medical face shield market as healthcare facilities place greater emphasis on protecting healthcare workers from exposure to respiratory droplets, blood, body fluids, and other potentially infectious materials during patient care. Face shields provide an additional facial barrier and can complement masks, respirators, protective gowns, and gloves, particularly during procedures with splash or aerosol risks. Hospitals, dental clinics, emergency departments, laboratories, and surgical settings are therefore incorporating face shields into broader personal protective equipment protocols. Greater attention to infection-control compliance is also encouraging healthcare institutions to maintain adequate PPE inventories and adopt products with features such as anti-fogging, clear visibility, comfortable headbands, and compatibility with other protective equipment. This sustained focus on occupational safety and infection prevention supports recurring institutional procurement and contributes to market demand.

For instance, in January 2025, CDC infection-control guidance recommended appropriate PPE for healthcare procedures that may produce splashes or sprays. It stated that procedures such as bronchoscopy, endotracheal suctioning, and invasive vascular procedures require a face shield or a mask with goggles when exposure to blood, body fluids, or respiratory secretions is expected.

The rising volume of tooth extraction procedures can support growth in the medical face shield market, as extractions involve direct manipulation of oral tissues and can expose dental professionals to blood, saliva, and other potentially infectious materials. Surgical extractions may also involve tissue incisions, bone removal, tooth sectioning, and suturing, creating situations in which splashes or spatter can occur. CDC guidance recommends that dental healthcare personnel use eye protection with side shields or a face shield during procedures likely to generate splashes or sprays of blood or body fluids. As dental practices perform more routine and surgical extractions, the need for protective equipment during these procedures supports recurring demand for medical face shields among dentists, oral surgeons, dental assistants, and other dental staff.

The rise in orthopedic surgeries supports the medical face shield market, as orthopedic procedures involve direct exposure to blood, body fluids, and surgical splashes, particularly during invasive operations such as joint replacement, fracture fixation, and trauma surgery. Procedures involving cutting, drilling, irrigation, or other surgical instruments can create situations where fluids may reach the face and eyes of healthcare personnel. CDC guidance for orthopedic and pain-management settings recommends appropriate PPE based on the expected exposure. It specifies the use of mouth, nose, and eye protection during procedures likely to generate splashes or sprays of blood or body fluids.

According to data published by the OECD in 2025, the graph and table below show hip replacement surgeries per 100,000 population in 2023.

Global Medical Face Shield Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global medical face shield market report based on product, usability, shield material, end-use, and region.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Standard Face Shields
• Wraparound / Extended-Coverage Face Shields
• Shield Usability Outlook (Revenue, USD Million, 2021 - 2033)
• Disposable Face Shields
• Reusable Face Shields
  • With Replaceable Visor
  • Without Replaceable Visor
• Shield Material Outlook (Revenue, USD Million, 2021 - 2033)
• PET / PETG
• Polycarbonate
• Acetate
• Others
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Dental Clinics
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Diagnostic Laboratories
• Emergency Medical Services (EMS)
• Others
• Region Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Norway
  • Denmark
  • Sweden
• Asia Pacific
  • China
  • Japan
  • South Korea
  • Thailand
  • Australia
  • India
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Usability
  • 1.1.3. Shield Material
  • 1.1.4. End Use
  • 1.1.5. Regional scope
  • 1.1.6. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Medical Face Shield Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising surgical procedures requiring enhanced facial protection
    • 3.2.1.2. Stronger infection-control protocols across healthcare facilities
    • 3.2.1.3. Growing awareness of occupational exposure risks
    • 3.2.1.4. Expansion of outpatient and ambulatory surgical centers
    • 3.2.1.5. Demand for comfortable, lightweight protective equipment
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Availability of alternative protective eyewear products
    • 3.2.2.2. Limited reuse potential for disposable face shields
  • 3.2.3. Market Opportunities Analysis
    • 3.2.3.1. Development of recyclable and sustainable shield materials
    • 3.2.3.2. Integration of anti-fog and scratch-resistant coatings
    • 3.2.3.3. Customized designs for specialized medical procedures
    • 3.2.3.4. Expansion across emerging healthcare infrastructure markets
    • 3.2.3.5. Integration with prescription eyewear and respiratory protection
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Maintaining optical clarity during prolonged procedures
    • 3.2.4.2. Balancing protection with comfort and ventilation
• 3.3. Medical Face Shield Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Medical Face Shield Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Medical Face Shield Market: Product Movement Analysis & Market Share, 2021 & 2033
• 4.3. Standard Face Shields
  • 4.3.1. Standard Face Shields Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.4. Wraparound / Extended-Coverage Face Shields
  • 4.4.1. Wraparound / Extended-Coverage Face Shields Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Medical Face Shield Market: Usability Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Medical Face Shield Market: Usability Movement Analysis & Market Share, 2021 & 2033
• 5.3. Disposable Face Shields
  • 5.3.1. Disposable Face Shields Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.4. Reusable Face Shields
  • 5.4.1. Reusable Face Shields Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.2. With Replaceable Visor
    • 5.4.2.1. With Replaceable Visor Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.3. Without Replaceable Visor
    • 5.4.3.1. Without Replaceable Visor Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Medical Face Shield Market: Shield Material Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Medical Face Shield Market: Shield Material Movement Analysis & Market Share, 2021 & 2033
• 6.3. PET / PETG
  • 6.3.1. PET / PETG Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.4. Polycarbonate
  • 6.4.1. Polycarbonate Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Acetate
  • 6.5.1. Acetate Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Others
  • 6.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Medical Face Shield Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Medical Face Shield Market: End Use Movement Analysis & Market Share, 2021 & 2033
• 7.3. Hospitals
  • 7.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.4. Dental Clinics
  • 7.4.1. Dental Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Ambulatory Surgical Centers (ASCs)
  • 7.5.1. Ambulatory Surgical Centers (ASCs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Specialty Clinics
  • 7.6.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Diagnostic Laboratories
  • 7.7.1. Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.8. Emergency Medical Services (EMS)
  • 7.8.1. Emergency Medical Services (EMS) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.9. Others
  • 7.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Medical Face Shield Market: Regional Estimates & Trend Analysis

• 8.1. Regional Outlook
• 8.2. Medical Face Shield Market: Regional Movement Analysis & Market Share, 2021 & 2033
• 8.3. North America
  • 8.3.1. North America Medical Face Shield Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Scenario
    • 8.3.2.4. Reimbursement Scenario
    • 8.3.2.5. U.S. Medical Face Shield Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Scenario
    • 8.3.3.4. Reimbursement Scenario
    • 8.3.3.5. Canada Medical Face Shield Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Competitive Scenario
    • 8.3.4.3. Regulatory Scenario
    • 8.3.4.4. Reimbursement Scenario
    • 8.3.4.5. Mexico Medical Face Shield Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe Medical Face Shield Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Scenario
    • 8.4.2.4. Reimbursement Scenario
    • 8.4.2.5. UK Medical Face Shield Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Scenario
    • 8.4.3.4. Reimbursement Scenario
    • 8.4.3.5. Germany Medical Face Shield Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Scenario
    • 8.4.4.4. Reimbursement Scenario
    • 8.4.4.5. France Medical Face Shield Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Scenario
    • 8.4.5.4. Reimbursement Scenario
    • 8.4.5.5. Italy Medical Face Shield Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Scenario
    • 8.4.6.4. Reimbursement Scenario
    • 8.4.6.5. Spain Medical Face Shield Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Scenario
    • 8.4.7.4. Reimbursement Scenario
    • 8.4.7.5. Denmark Medical Face Shield Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Scenario
    • 8.4.8.4. Reimbursement Scenario
    • 8.4.8.5. Sweden Medical Face Shield Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Scenario
    • 8.4.9.4. Reimbursement Scenario
    • 8.4.9.5. Norway Medical Face Shield Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific Medical Face Shield Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Scenario
    • 8.5.2.4. Reimbursement Scenario
    • 8.5.2.5. Japan Medical Face Shield Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Scenario
    • 8.5.3.4. Reimbursement Scenario
    • 8.5.3.5. China Medical Face Shield Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Scenario
    • 8.5.4.4. Reimbursement Scenario
    • 8.5.4.5. India Medical Face Shield Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Scenario
    • 8.5.5.4. Reimbursement Scenario
    • 8.5.5.5. South Korea Medical Face Shield Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.6. Australia
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Scenario
    • 8.5.6.4. Reimbursement Scenario
    • 8.5.6.5. Australia Medical Face Shield Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.7. Thailand
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Scenario
    • 8.5.7.4. Reimbursement Scenario
    • 8.5.7.5. Thailand Medical Face Shield Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America Medical Face Shield Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Scenario
    • 8.6.2.4. Reimbursement Scenario
    • 8.6.2.5. Brazil Medical Face Shield Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Scenario
    • 8.6.3.4. Reimbursement Scenario
    • 8.6.3.5. Argentina Medical Face Shield Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.7. Middle East & Africa
  • 8.7.1. Middle East & Africa Medical Face Shield Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Scenario
    • 8.7.2.4. Reimbursement Scenario
    • 8.7.2.5. South Africa Medical Face Shield Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Scenario
    • 8.7.3.4. Reimbursement Scenario
    • 8.7.3.5. Saudi Arabia Medical Face Shield Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Scenario
    • 8.7.4.4. Reimbursement Scenario
    • 8.7.4.5. UAE Medical Face Shield Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Scenario
    • 8.7.5.4. Reimbursement Scenario
    • 8.7.5.5. Kuwait Medical Face Shield Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
  • 9.2.1. Innovators
• 9.3. Vendor Landscape
  • 9.3.1. List of key distributors and channel partners
  • 9.3.2. Key customers
• 9.4. Global Key company market share analysis, 2024
  • 9.4.1. Solventum (3M)
    • 9.4.1.1. Company Overview
    • 9.4.1.2. Financial Performance
    • 9.4.1.3. Product Benchmarking
    • 9.4.1.4. Strategic Initiatives
  • 9.4.2. Cardinal Health
    • 9.4.2.1. Company Overview
    • 9.4.2.2. Financial Performance
    • 9.4.2.3. Product Benchmarking
    • 9.4.2.4. Strategic Initiatives
  • 9.4.3. Molnlycke Health Care
    • 9.4.3.1. Company Overview
    • 9.4.3.2. Financial Performance
    • 9.4.3.3. Product Benchmarking
    • 9.4.3.4. Strategic Initiatives
  • 9.4.4. AlphaProTech
    • 9.4.4.1. Company Overview
    • 9.4.4.2. Financial Performance
    • 9.4.4.3. Product Benchmarking
    • 9.4.4.4. Strategic Initiatives
  • 9.4.5. Dukal, LLC
    • 9.4.5.1. Company Overview
    • 9.4.5.2. Financial Performance
    • 9.4.5.3. Product Benchmarking
    • 9.4.5.4. Strategic Initiatives
  • 9.4.6. Tecman Advanced Healthcare Products
    • 9.4.6.1. Company Overview
    • 9.4.6.2. Financial Performance
    • 9.4.6.3. Product Benchmarking
    • 9.4.6.4. Strategic Initiatives
  • 9.4.7. Weigao Medical International Co., Ltd
    • 9.4.7.1. Company Overview
    • 9.4.7.2. Financial Performance
    • 9.4.7.3. Product Benchmarking
    • 9.4.7.4. Strategic Initiatives
  • 9.4.8. Wujiang TTK
    • 9.4.8.1. Company Overview
    • 9.4.8.2. Financial Performance
    • 9.4.8.3. Product Benchmarking
    • 9.4.8.4. Strategic Initiatives
  • 9.4.9. TIDI Products (TJC, L.P.)
    • 9.4.9.1. Company Overview
    • 9.4.9.2. Financial Performance
    • 9.4.9.3. Product Benchmarking
    • 9.4.9.4. Strategic Initiatives
  • 9.4.10. Dynarex Corporation
    • 9.4.10.1. Company Overview
    • 9.4.10.2. Financial Performance
    • 9.4.10.3. Product Benchmarking
    • 9.4.10.4. Strategic Initiatives
  • 9.4.11. Medline
    • 9.4.11.1. Company Overview
    • 9.4.11.2. Financial Performance
    • 9.4.11.3. Product Benchmarking
    • 9.4.11.4. Strategic Initiatives
  • 9.4.12. Keystone Vet
    • 9.4.12.1. Company Overview
    • 9.4.12.2. Financial Performance
    • 9.4.12.3. Product Benchmarking
    • 9.4.12.4. Strategic Initiatives
  • 9.4.13. Others
• 9.5. Heat Map Analysis/ Company Market Position Analysis
• 9.6. Estimated Company Market Share Analysis, 2025
• 9.7. List of Other Key Market Players